140 results
8-K
EX-2.1
SIENQ
Sientra Inc
18 Apr 24
Financial Statements and Exhibits
5:19pm
pursuant to its “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities” Final Policy set forth in 56 Fed. Reg. 46191 (September 10 … provide a basis for the FDA to invoke its policy with respect to “Fraud, Untrue Statements of Material Facts, Bribery and Illegal Gratuities” and any
8-K
EX-10.1
SIENQ
Sientra Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:15pm
related to: (a) fraud and abuse, including, without limitation, the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)), the Eliminating … False Claims Act (18 U.S.C. § 287), the False Statements Relating to Health Care Matters Act (18 U.S.C. § 1035), the Health Care Fraud Act (18 U.S.C
8-K
EX-10.1
SIENQ
Sientra Inc
13 Feb 24
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
9:00am
to: (a) fraud and abuse, including, without limitation, the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)), the Eliminating Kickbacks … Claims Act (18 U.S.C. § 287), the False Statements Relating to Health Care Matters Act (18 U.S.C. § 1035), the Health Care Fraud Act (18 U.S.C. § 1347
8-K
EX-10.1
SIENQ
Sientra Inc
29 Jan 24
Entry into a Material Definitive Agreement
6:07am
set forth in this Agreement and (ii) any Released Matters arising from the bad faith, gross negligence, willful misconduct or actual fraud of any
8-K
EX-10.1
SIENQ
Sientra Inc
16 Jan 24
Entry into a Material Definitive Agreement
4:10pm
in this Agreement and (ii) any Released Matters arising from the bad faith, gross negligence, willful misconduct or actual fraud of any Releasee.
(b) Each
8-K
EX-10.1
tlvn9hio3vmcrc
31 Oct 23
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial
6:12am
8-K
EX-1.1
nq1lz vl7pft9460
27 Oct 22
Sientra Announces Proposed Public Offering
4:28pm
8-K
EX-10.1
q4s11cxdw
12 Oct 22
Sientra Announces Preliminary Unaudited Third Quarter Financial
9:06am